Clawback: The Innovative Pharma Market is Collapsing

News

Fewer than 2 out of 10 treatments are covered by the state, severely limiting patients’ access to innovative and critical therapies. Following the meeting between the Minister of Health, Mr. Adonis Georgiadis, and the pharmaceutical industry associations, the issue of mandatory clawback payments for the first half of 2023 is being hastily addressed, with the…

Clawback: Pharmaceutical Companies in a Deadlock

News

PhARMA Innovation Forum (PIF) and its 26 biopharmaceutical member companies express their deep concern over the impasse regarding patient access to innovative therapies. According to official data from the National Central Purchasing Body for Health Sector (EKAPY), shared with our companies and covering the first half of 2023, the mandatory clawbacks due to budget overruns…